Scarab Genomics: Theraly Fibrosis Inc. Licenses Scarab Genomics' Bacterial Production Technologies for its Pharmaceutical Program

Scarab Genomics LLC and Theraly Fibrosis Inc. announced that they have entered into a license agreement to allow Theraly Fibrosis to fully exploit Scarab Genomics' technology for the production of a protein for its core therapeutic program.